FDA OKs Plavix for Severe Heart Attack Patients
Posted on: Monday, 11 September 2006, 15:00 CDT
The FDA has approved Bristol-Myers Squibb's blood-thinning drug Plavix as a new option for patients with the most severe type of heart attack.
The FDA approved the use of Plavix, which Bristol-Myers Squibb produces in partnership with Sanofi-Aventis, to reduce the risk of death from any cause and the risk of a combined endpoint of recurrent heart attack, stroke or death in patients with acute ST-elevation myocardial infarction (STEMI) - the most severe type of heart attack.
Commenting on the FDA decision, Dr Steven Steinhubl from the University of Kentucky said: "The new Plavix indication is an important milestone for patients diagnosed with acute coronary syndrome, which includes heart-related chest pain or any type of heart attack, no matter how severe."
According to the makers of Plavix, each year more than 300,000 Americans suffer a severe type of heart attack - also known as a STEMI event. STEMI is a heart attack in which an artery is generally blocked completely and patients who have experienced STEMI and survive are at high risk of having another heart attack, a stroke or even dying.
Source: Datamonitor
Related Articles
- Elevated Biomarkers Lead To Diminished Quality Of Life In Heart Attack Patients Post-Discharge
- Acute Heart Attack Patients Receiving High Ionizing Radiation Dose
- Outcomes Registry in Heart Attack Patients to Generate Numerous Studies; Data Quality Ensured Through Velos Clinical Research Management System
- New Analysis From HORIZONS-AMI Shows Major Bleeding Has a Significant Impact and Contributes to 30-Day Mortality Following Angioplasty in Severe Heart Attack Patients
- Medicines Company's Angiomax Shows Improved Outcomes in Heart Attack Patients
- Angiomax(R) / Angiox(R) (Bivalirudin) Significantly Improved Net Outcomes in Heart Attack Patients
- Innovative Treatment for Heart Attack Patients Reaches Milestone
- Distress, Fear often Beset Heart Attack Patients
- Scientists Challenge the Use of B Vitamins for Heart Attack Patients
- Invasive Treatment May Be More Effective for Heart Attack Patients Presenting Late to Hospital
 |
 |
User Comments (0)
RSS Feeds